Weight-related comorbidity

Clinical trials for Weight-related comorbidity explained in plain language.

Never miss a new study

Get alerted when new Weight-related comorbidity trials appear

Sign up with your email to follow new studies for Weight-related comorbidity, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Can a new weekly shot boost weight loss beyond current therapies?

Disease control Not yet recruiting

This phase 3 trial is testing whether an experimental drug called AZD6234, given as a weekly injection, can help adults with obesity or overweight lose more weight when added to their current incretin-based therapy. The study includes about 500 participants who either have type 2…

Matched conditions: WEIGHT-RELATED COMORBIDITY

Phase 3 • Sponsor: AstraZeneca • Aim: Disease control

Last updated Aug 22, 2026 00:00 UTC

Weight-related comorbidity

Get alerted when new Weight-related comorbidity trials appear

Can a new weekly shot boost weight loss beyond current therapies?